Lord, Abbett & Co. LLC Insmed Inc Transaction History

Lord, Abbett & Co. LLC

$30.6 Billion
Q2 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Insmed Inc stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 582,577 shares of INSM stock, worth $41.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

582,577

Holding current value

$41.8 Million

% of portfolio

0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	BUY	$22.0 - $69.71 $10.4 Million - $33 Million	473,472 Added 433.96%	582,577 $39 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $12.8 Million - $40.6 Million	582,577 New	582,577 $39 Million
Q4 2022 Oct 07, 2024	SELL	$16.98 - $23.15 $8.04 Million - $11 Million	-473,472 Reduced 81.27%	109,105 $2.18 Million
Q4 2022 Feb 10, 2023	SELL	$16.98 - $23.15 $1.82 Million - $2.48 Million	-107,121 Reduced 49.54%	109,105 $2.18 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $148,811 - $201,052	7,127 Added 3.41%	216,226 $4.66 Million
Q2 2022 Aug 12, 2022	BUY	$17.07 - $25.71 $241,745 - $364,105	14,162 Added 7.26%	209,099 $4.12 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $71,163 - $98,033	3,485 Added 1.82%	194,937 $4.58 Million
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $47,197 - $60,979	-1,823 Reduced 0.94%	191,452 $5.22 Million
Q3 2021 Nov 09, 2021	SELL	$22.46 - $29.47 $54,959 - $72,113	-2,447 Reduced 1.25%	193,275 $5.32 Million
Q2 2021 Aug 11, 2021	SELL	$24.17 - $36.01 $50.7 Million - $75.6 Million	-2,098,582 Reduced 91.47%	195,722 $5.57 Million
Q1 2021 May 11, 2021	BUY	$32.28 - $44.3 $9.35 Million - $12.8 Million	289,765 Added 14.46%	2,294,304 $78.1 Million
Q4 2020 Feb 09, 2021	BUY	$31.45 - $40.54 $20.7 Million - $26.6 Million	657,075 Added 48.76%	2,004,539 $66.7 Million
Q3 2020 Nov 12, 2020	BUY	$26.0 - $34.5 $29.2 Million - $38.7 Million	1,122,357 Added 498.59%	1,347,464 $43.3 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $1.68 Million - $3.5 Million	-118,851 Reduced 34.55%	225,107 $6.2 Million
Q1 2020 May 14, 2020	BUY	$13.63 - $33.98 $2.16 Million - $5.39 Million	158,738 Added 85.7%	343,958 $5.51 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $2.99 Million - $4.63 Million	185,220 New	185,220 $4.42 Million
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $11.8 Million - $17.4 Million	-620,112 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $3.59 Million - $5.34 Million	-179,621 Reduced 22.46%	620,112 $14.7 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $2.15 Million - $3.27 Million	99,162 Added 14.15%	799,733 $18 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $21.3 Million - $25.7 Million	-807,139 Reduced 53.53%	700,571 $21.8 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $17.5 Million - $47.1 Million	1,507,710	1,507,710 $47.1 Million

Others Institutions Holding INSM

# of Institutions

455

Shares Held

173M

Call Options Held

5.75M

Put Options Held

5.11M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.71B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Insmed Inc Transaction History